Triglyceride-rich particles, high-density lipoprotein and their pharmacological modulation.
Bard
J M
JM
Serlia et Inserm U325, Institut Pasteur, Lille, France.
Fruchart
J C
JC
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001054:Apolipoproteins A / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D001055:Apolipoproteins B / Q000032:analysis / Q000187:drug effects / Q000378:metabolism*; D015415:Biomarkers / Q000097:blood; D002792:Cholestyramine Resin; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D008074:Lipoproteins / Q000097:blood* / Q000187:drug effects; D014280:Triglycerides / Q000097:blood*
D000924:Anticholesteremic Agents; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D015415:Biomarkers; D008074:Lipoproteins; D014280:Triglycerides; D002792:Cholestyramine Resin